Powered Exoskeleton Combined With Functional Electrical Stimulation in Clinical Practice
NCT ID: NCT04568928
Last Updated: 2022-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2020-12-10
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury
NCT02322125
Multimodal Exercises to Improve Leg Function After Spinal Cord Injury
NCT01740128
Evaluation of Robotic Exoskeletons Therapy for Gait Rehabilitation in Patients With Incomplete Spinal Cord Injury.
NCT03477123
Overground Walking Program With Robotic Exoskeleton in Long-term Manual Wheelchair Users With Spinal Cord Injury
NCT03989752
Robotic Exoskeleton With Functional Electrical Stimulation in Acute Spinal Cord Injury
NCT04250688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OLTP/PE+FES
3-5 familiarization sessions + 12 training sessions (3 blocks of 4 training sessions; 60-90 min each session, 2-3 sessions per week) of an overground locomotor training program using a powered exoskeleton combined with functional electrical stimulation (OLTP/PE+FES).
The training sessions are divided into 3 blocks. Each block will take place over a period of approximately 2 weeks (2-3 sessions/week) and will consist of 3 training sessions with exoskeleton combined with FES and a fourth session with exoskeleton alone, without FES.
For each participant, FES intensity will be set for each muscle in order to elicit a palpable muscle contraction. FES timing and duration is already built into the device. For each participant, specific level of assistance for each hip and knee, and gait parameters will be set and adjusted during a familiarization period with the PE. Level of PE assistance will then be adjusted weekly to ensure training progression.
OLTP/PE + FES
12 sessions OLTP/PE + FES
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OLTP/PE + FES
12 sessions OLTP/PE + FES
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Measure between 5'1" and 6'3" (1.5 and 1.9m)
* Weigh less than 200 pounds (90kg)
* Present a diagnosis of incomplete spinal cord injury
* Have the ability to maintain a standing position and/or have therapeutic walking ability at Stage 1B or more of the Rick Hansen Institute SCI Standing and Walking Assessment Toolkit
* Present sufficient upper extremity strength and function to use a walker with wheels
* Femur length between 37 and 49cm
* Width of hips when seated \<42 cm
* Obtain approval from a physician to participate in the project
* Standing tolerance \>15 minutes
For FES:
* Respond favourably to functional electrical stimulation (FES) of the main lower extremity muscle groups: (gluteus, quadriceps, hamstrings, dorsiflexors, etc.) as determined by a physiotherapist.
* Have no contraindications to FES according to the guidelines of the Canadian physiotherapy association (CPA).
Exclusion Criteria
* Poor fit of the exoskeleton as determined by the research team
* Present contraindications to the use of the Indego® exoskeleton as described by the company
* Present lower extremity skin lesions or sores
* Any medical condition or co-morbidity that may impair collaboration and participation or making it unsafe to wear the exoskeleton, for example (non-exhaustive list) :
* Disabling pain.
* Significant sensory disturbances in the lower limbs that limit safe walking.
* Cognitive disorders that impair the ability to collaborate.
* Osteoporosis.
* Unconsolidated fractures of the lower limbs.
* Uncontrolled reflex dysautonomia.
* Severe peripheral vascular disease.
* Severe heart failure.
* Severe, active infection
* Pregnancy;
* Presence of a malignant tumor
* Deep vein thrombosis
* Hemorrhagic condition
* Infection or osteomyelitis
* Presence of weakened/damaged skin
* Circulatory disorders
* Epilepsy
* Electronic implant
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Praxis Spinal Cord Institute
OTHER
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
François Routhier
Full Professor/ Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François Routhier, PhD
Role: PRINCIPAL_INVESTIGATOR
Laval University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laval University
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-2002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.